Detralex of the tab. of p/o of 1000 mg No. 18

tablets Detralex are shown at:

• Symptomatic treatment of venolimfatichny insufficiency (weight in legs, pain, night spasms, hypostases, trophic violations, including varicose ulcers).
• Symptomatic treatment of hemorrhoids.

Structure

Active ingredient: the micronized cleaned flavonoidny fraction (diosmin + flavonoids in the form of hesperidin);

1 tablet contains 1000 mg micronized cleaned flavonoidny fractions, contains 900 mg of diosmin (90%) and 100 mg of flavonoids in the form of hesperidin (10%);

Excipients: microcrystalline cellulose, gelatin, magnesium stearate, starch sodium (type A), talc, water cleaned;

Film cover: glycerin, gipromelloza, macrogoal 6000, magnesium stearate, ferrous oxide red (E172), sodium lauryl sulfate, titan dioxide (E 171), ferrous oxide yellow (E 172).

Contraindication

Hypersensitivity to active ingredient or to any of excipients.

Route of administration

For oral administration.

only for division of a tablet for swallowing simplification, but not for division into equal parts.

It is appointed adult.

Duration of therapy is defined by the doctor depending on indications and a course of the disease.

Feature of application

Pregnant and feeding with a breast

Data on application of the micronized cleaned flavonoidny fraction by pregnant women are absent or their quantity is limited. Researches on animals did not show teratogenic effect.

As a measure of restraint it is desirable for p to avoid use of medicine during the pregnancy period.

a breast

Does not know Feeding whether active ingredient or its metabolites gets into breast milk. The risk for newborns/babies cannot be excluded. The decision on the feeding termination by a breast or termination/abstention from therapy by this medicine should be accepted, considering advantage of feeding by a breast for the child and advantage of treatment for mother.

Children

Data on use of the medicine Detralex of 1000 Mg to children are absent.

Drivers

Research of influence of flavonoidny fraction on ability to steer motor transport or to work with other mechanisms. However, according to the general profile of safety of flavonoidny fraction, Detralex ® 1000 mg do not influence or have insignificant influence on this ability.

Overdose

About cases of overdose it was not reported.

Side effects

side effects of moderate intensity, mainly from digestive tract (diarrhea, dyspepsia, nausea, vomiting).

Despite wide postregistration experience of use of the medicine Detralex by

about interaction.

Storage conditions

does not demand special storage conditions. To store out of children's reach. An expiration date - 4 years.